Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
Myotonic dystrophy type 1 (DM1) is caused by DM protein kinase (DMPK) transcripts containing an expanded (CUG)n repeat. Antisense oligonucleotide (AON)-mediated suppression of these mutant RNAs is considered a promising therapeutic strategy for this severe disorder. Earlier, we identified a 2′-O-met...
Main Authors: | Anchel González-Barriga, Susan AM Mulders, Jeroen van de Giessen, Jeroen D Hooijer, Suzanne Bijl, Ingeborg DG van Kessel, Josee van Beers, Judith CT van Deutekom, Jack AM Fransen, Bé Wieringa, Derick G Wansink |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S216225311630141X |
Similar Items
-
The regulation of alternative splicing associated with Myotonic Dystrophy
by: Warf, Michael Bryan
Published: (2010) -
Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR
by: Susmita eSingh, et al.
Published: (2014-04-01) -
Targeting Myotonic Dystrophy with Small Molecules
by: Coonrod, Leslie, et al.
Published: (2012) -
Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
by: Laurène M. André, et al.
Published: (2018-05-01) -
microRNA-mRNA Profile of Skeletal Muscle Differentiation and Relevance to Congenital Myotonic Dystrophy
by: Sarah U. Morton, et al.
Published: (2021-03-01)